Menu

Markets

Dugar Finance Raises $3 Million to Boost EV, Solar Lending

Dugar Finance Raises $3 Million to Boost EV, Solar Lending

Dugar Finance Raises $3 Million to Boost EV, Solar Lending

Dugar Finance and Investments Limited, a Chennai-headquartered non-banking financial company (NBFC), has secured $3 million via Symbiotics’ Green Basket Bond program. This significant funding is set to enhance Dugar Finance’s focus on supporting electric vehicle (EV) and rooftop solar loan segments, particularly in underserved markets.

About the Green Basket Bond

The Green Basket Bond, launched by Symbiotics Investments, is a $75 million investment instrument dedicated to promoting sustainable finance. The bond is specifically designed to channel funds into climate-positive initiatives across emerging economies. Notably, this bond is backed by the British International Investment (BII), the UK’s development finance institution, which is actively investing in green financial instruments to address global climate change challenges.
Dugar Finance’s participation in this bond positions it as a key player in sustainable lending, with a sharp focus on sectors contributing to environmental improvements. The company plans to deploy the newly acquired funds towards expanding its green loan portfolio, particularly targeting electric mobility and solar energy solutions.

Targeting Underserved Markets

A significant aspect of Dugar Finance’s strategy involves concentrating its efforts on customers in India’s tier-II and tier-III cities. These areas, often overlooked by large financial institutions, hold untapped potential for sustainable growth. The company will offer tailored financial products to residential customers, micro, small, and medium-sized enterprises (MSMEs), and housing societies.
By extending affordable loans for EV purchases and rooftop solar installations, Dugar Finance aims to bridge the gap in green financing access. The company’s approach aligns with national and global efforts to foster cleaner transportation and energy solutions at the grassroots level.

Environmental and Financial Impact

The impact of Dugar Finance’s green lending strategy is already visible. To date, the company has financed approximately 1,200 customers who have either installed rooftop solar systems or purchased electric vehicles. These initiatives have collectively contributed to reducing carbon emissions by an estimated 3,000 tonnes.
Furthermore, the customers supported by Dugar Finance have reported total annual electricity savings of nearly ₹2.96 crore. Such tangible benefits underline the dual value of the company’s financial products—promoting environmental sustainability while delivering direct economic advantages to consumers.

Leadership Insights

Ramesh Dugar, the Founder and Managing Director of Dugar Finance, highlighted the importance of this strategic funding. According to him, the funding from Symbiotics is more than just financial support; it serves as a validation of the company’s vision to integrate sustainability with financial inclusion.
“This investment reflects our dedication to developing financial solutions that not only promote expansion but also actively support environmental progress. We are proud to be part of the global green finance movement that is reshaping the future of energy and transportation,” said Dugar.
His remarks reflect the company’s broader mission to empower smaller businesses and individual customers while simultaneously contributing to India’s renewable energy targets and green mobility transition.

Driving Sustainable Finance in India

Dugar Finance’s collaboration with Symbiotics, backed by BII, underscores the rising significance of green finance within India’s transforming financial sector. The company’s efforts align with the Indian government’s push to encourage electric mobility and the adoption of renewable energy sources to combat climate change.
Financial institutions like Dugar Finance are playing a pivotal role in enabling this transition by offering accessible financing options tailored to the unique needs of emerging markets. Their focus on underpenetrated regions and smaller customer segments is helping democratize the benefits of sustainable technology adoption.

Expanding the Green Footprint

Looking forward, Dugar Finance aims to steadily expand its green lending programs. The company will actively seek further partnerships and investments that support its vision of broadening financial inclusion through environmentally responsible financing.
With a defined path for growth and a solid history of delivering results, Dugar Finance stands ready to advance India’s sustainable development objectives. By offering affordable, targeted loan products for EVs and rooftop solar systems, the company is empowering consumers and small businesses to participate in the green revolution.

Conclusion

Dugar Finance’s achievement in raising $3 million via Symbiotics’ Green Basket Bond highlights the growing international emphasis on funding initiatives that promote environmental sustainability. By channeling these funds into electric vehicle and rooftop solar financing, especially in underserved regions, the company is setting a strong example of how NBFCs can lead in the sustainable finance sector.
This initiative not only strengthens Dugar Finance’s market position but also accelerates the transition towards cleaner energy and transportation in India. As green finance continues to gain momentum, Dugar Finance’s proactive approach serves as a blueprint for inclusive and sustainable economic growth.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

₹40 Stock Gains Spotlight After ₹30 Crore CP Repayment

Liquor stocks beat FMCG peers in one year; 3 rally drivers & 3 future growth triggers

₹40 Stock Gains Spotlight After ₹30 Crore CP Repayment

₹40 Stock Gains Spotlight After ₹30 Crore CP Repayment

Paisalo Digital repays ₹30 crore CP, boosting market confidence.

Paisalo Digital Ltd, a low-priced non-banking financial company (NBFC) trading below ₹40, caught investors’ attention after it successfully redeemed commercial papers (CPs) worth ₹30 crore upon maturity. This full repayment, completed as scheduled, strengthened the company’s financial credibility and sparked a positive reaction in the stock market.

The commercial papers in question were issued earlier at an interest rate of 11%, with each CP valued at ₹5 lakh. In total, **600 units were privately placed with State Bank of India (SBI), marking a short-term borrowing of ₹30 crore. The company completed the redemption on March 20, 2025, as planned, signaling strong financial discipline.

Soon after the announcement, Paisalo’s shares jumped intraday to ₹36.46, a gain of more than 6% on the BSE. The stock eventually settled close to ₹36, showing renewed interest from retail investors and traders encouraged by the company’s prompt debt servicing.

The successful redemption indicates that Paisalo Digital is in a healthy liquidity position. The company has maintained a net cash-positive balance sheet, with no outstanding debt—a strong indicator of financial strength in a volatile NBFC environment. While its share price has faced pressure over the past year, sliding nearly 50%, the stock has delivered around 300% returns over five years, reflecting long-term potential.

In addition to domestic fundraising through commercial papers, Paisalo has also tapped global capital markets. The company had previously listed Foreign Currency Convertible Bonds (FCCBs) worth \$48 million on the Mauritius International Financial Centre (IFSC), further enhancing its financial flexibility.

Operationally, Paisalo has shown consistent growth. For Q3 FY25, the company posted a net profit of ₹62.4 crore, up over 10% year-on-year, with total revenues touching ₹203.8 crore. Its assets under management (AUM) reached ₹4,622 crore in Q4, reflecting a 32% rise compared to the previous year. Loan disbursements also grew by about 38%, showcasing strong demand for its credit services.

The company’s business model focuses on inclusive financial solutions and micro-lending, particularly targeting underserved markets.

Major institutional investors, including SBI Life Insurance and Life Insurance Corporation of India (LIC), hold stakes in the company—adding to its credibility and signaling confidence from long-term capital providers.

Investor Takeaways

Paisalo Digital’s full repayment of ₹30 crore in commercial papers sends a clear message about its liquidity strength and financial discipline. Timely redemption improves its reputation with institutional investors and debt markets, a critical factor for NBFCs relying on short-term borrowings.

With growing AUM, improving profits, a broad customer base, and solid backing from institutions, Paisalo has the potential to rebound—provided it maintains control over credit risk and continues to access affordable funding.

That said, investors should be mindful of ongoing sectoral volatility. The stock is still trading below key moving averages and has seen sharp corrections in recent months.

Summary

Paisalo Digital Ltd, a stock priced under ₹40, saw renewed market interest after it fully repaid ₹30 crore worth of commercial papers on their maturity date. The move reflects its strong liquidity profile and disciplined financial management, supported by rising profits, expanding AUM, and institutional backing.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

International Conveyors Shares Rally Over 15% Following Promoter Stake Expansion

International Conveyors Shares Rally Over 15% Following Promoter Stake Expansion

International Conveyors Shares Rally Over 15% Following Promoter Stake Expansion

International Conveyors Shares Rally Over 15% Following Promoter Stake Expansion

International Conveyors Ltd (ICL) recently witnessed a notable increase in its stock value, recording a gain exceeding 15% in a single trading session. This significant upward movement was largely driven by a rise in the promoter’s ownership, often regarded as a promising indicator for the company’s future path.

Promoters Expand Their Holdings

International Conveyors’ stock, which had previously traded under ₹90, experienced a strong boost after the promoters added to their shareholding. On June 12, 2025, the promoters acquired 59,941 shares at an average rate of ₹86.60 per share, lifting their total ownership to about 0.76%, equating to 4,79,803 units.
Further solidifying their position, the promoters purchased another 33,688 shares on June 13, 2025, at an average cost of ₹85.70 per share. This brought their combined stake to approximately 0.81%, amounting to 5,13,491 shares. These purchases were officially reported to the stock exchanges on June 17, 2025. Repeated promoter buying is commonly seen as a firm indication of the management’s long-term belief in the company’s potential.

Notable Stock Performance

Post these acquisitions, International Conveyors’ share price surged to an intraday peak of ₹90.30 from the previous closing rate of ₹78.04, marking a sharp increase of nearly 15.7%. The stock market responded positively to the promoter’s continuous buying, with many interpreting it as a reflection of internal confidence in the company’s outlook.
Typically, increasing promoter holdings are viewed as positive signals, enhancing investor confidence in the company’s growth trajectory.

Strategic Investment: JSW One Platforms

In addition to the promoter’s stake expansion, International Conveyors recently made a calculated investment in JSW One Platforms Ltd. The company obtained 710 Compulsorily Convertible Preference Shares (CCPS) of JSW One, allocating a total investment of ₹40.24 crore.
JSW One Platforms is an emerging B2B e-commerce player dedicated to optimizing industrial supply chains. The company reported a turnover of ₹3,962.8 crore in the fiscal year 2024-25. International Conveyors’ investment in this platform highlights its approach to diversifying into promising digital sectors aligned with industrial advancements.

Strong Financial Performance

International Conveyors posted impressive financial results for the March 2025 quarter. The company’s revenue climbed by 64%, reaching ₹56.07 crore compared to ₹34.12 crore in the same quarter of the previous fiscal. Its net profit more than doubled, rising to ₹13.03 crore from ₹6.07 crore on a year-over-year basis.
The company upholds a stable financial foundation, demonstrated by a debt-to-equity ratio of 0.24, suggesting limited borrowing pressure. Its price-to-earnings (P/E) ratio stands at around 6.09, considerably lower than the sector average of approximately 33.9, suggesting attractive valuations. Additionally, its price/earnings to growth (PEG) ratio of about 0.13 signifies favorable pricing when compared to its profit expansion.
Over the past three years, International Conveyors has consistently delivered an average profit growth of 56.8%. Promoters currently own more than 65% of the company’s total shares, which further strengthens investor trust in the company’s operational stability.

Company Profile and Market Reach

Founded in 1973 and headquartered in Aurangabad, International Conveyors is globally recognized for its specialization in manufacturing PVC conveyor belts. The company is the world’s second-largest producer in this category, with over 90% of its output exported to key international markets, including the United States, Canada, Australia, and South Africa.
The company serves a highly reputable clientele, including major names such as Shree Cement, Tata Steel, Coal India, and Glencore. This broad global presence and long-standing customer partnerships have significantly contributed to its sustained success and industry reputation.

Conclusion

The recent increase in International Conveyors’ share value is closely tied to the promoter’s active investment and the company’s strategic move into new business areas. Supported by robust financial growth, attractive valuation metrics, and a wide global footprint, these factors position International Conveyors as a promising choice for long-term investors.
As the company continues to pursue fresh growth initiatives and reinforce its market presence, it is expected to retain substantial investor interest focused on future performance.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Man Infraconstruction Restructures LLP Stake, Holds Control Amid ₹503 Cr EPC Pipeline

Indian Startups Accelerate IPO Parade as Market Matures in 2025

BlueStone Eyes $1.2B Valuation Ahead of IPO

BlueStone Eyes $1.2B Valuation Ahead of IPO

With a soaring valuation, robust financial growth, and strong investor interest, BlueStone is poised to become India’s next unicorn as it readies for a landmark public market debut.

Introduction
BlueStone, one of India’s leading omnichannel jewellery brands gearing up for its IPO, is on track to achieve unicorn status. Recent secondary transactions and funding rounds have valued the Bengaluru-based company at approximately $1.2 billion (Rs 10,500 crore), marking a 30% jump from its last valuation. As BlueStone prepares for a major IPO, the company’s growth trajectory, investor exits, and financial performance are drawing significant attention in the startup and retail sectors.

BlueStone’s Valuation Soars: The Road to Unicorn Status
BlueStone’s journey toward unicorn status has accelerated in recent months. Recent secondary transactions involving existing and incoming investors have elevated the company’s valuation to ₹10,500 crore ($1.2 billion), a significant rise from ₹8,100 crore during its August 2024 funding round. This leap reflects both the company’s robust revenue growth and the bullish sentiment among investors toward India’s organised jewellery sector.
The unicorn milestone is not just symbolic; it signals BlueStone’s readiness to compete with legacy players and digital-first brands alike. The company’s omnichannel strategy, which blends online and offline retail, has enabled it to capture a broad customer base and adapt quickly to shifting market dynamics.

IPO Plans: Structure and Strategic Moves
BlueStone’s IPO preparations are in full swing. BlueStone submitted its DRHP to SEBI in December 2024 and received the regulatory nod in April 2025. The public offering is expected to include:
• A proposed ₹1,000 crore capital raise
• An offer-for-sale (OFS) of nearly 24 million shares, allowing early investors and venture capital funds to partially or fully exit their stakes
Major investors such as Accel, Saama Capital, IvyCap Ventures, and Kalaari Capital are set to participate in the OFS, while Singapore-based RB Investments will make a complete exit, reportedly earning a 10–12x return on its investment. Wealth management firms such as 360 One and Centrum Wealth are enabling secondary transactions valued between ₹300–350 crore in the run-up to the IPO.

Funding Momentum and Investor Confidence
BlueStone’s funding history underscores its appeal to both domestic and international investors. In August 2024, BlueStone closed a ₹900 crore funding round backed by investors such as Peak XV Partners, Prosus, Steadview Capital, Think Investments, and Pratithi Investments, led by Infosys cofounder Kris Gopalakrishnan. BlueStone raised ₹40 crore in debt financing from BlackSoil and Caspian Impact Investments in May 2025, further strengthening its financial position.
BlueStone’s rising valuation reflects the broader growth momentum within India’s jewellery industry. The Tata Group’s acquisition of CaratLane at a Rs 17,000 crore valuation has sparked renewed investor interest in omnichannel jewellery brands, with startups like Giva also attracting significant capital.

Financial Performance: Revenue Growth and Profitability Trends
BlueStone’s financials reflect a company in rapid expansion mode. The retailer posted revenues of ₹1,266 crore for FY24, marking a 64% year-on-year growth. Losses have narrowed as well, with the FY24 net loss shrinking to Rs 142 crore, down from Rs 167 crore in the previous year.
The momentum has carried into FY25, with BlueStone posting operating revenue of Rs 348 crore and a net loss of Rs 59 crore in the first quarter alone. This trajectory signals improving operational efficiency and a path toward profitability, a key consideration for public market investors.

Sector Context: Jewellery Retail’s Digital Revolution
BlueStone’s rise comes amid a broader digital transformation in India’s jewellery market. The company’s omnichannel approach—combining a strong online presence with physical stores—has given it an edge in a sector traditionally dominated by legacy brands. This model allows BlueStone to offer customers convenience, transparency, and a wide assortment of designs, while also building trust through in-person experiences.
Investor enthusiasm for the sector is also buoyed by the success of peers like CaratLane and the growing trend of organized retail in jewellery, which is rapidly eating into the market share of unorganized players.

Conclusion
BlueStone’s imminent unicorn status and IPO plans mark a watershed moment for India’s jewellery retail industry. With a $1.2 billion valuation, strong revenue growth, and a blend of digital and physical retail strategies, the company is well-positioned to capitalize on changing consumer preferences and investor appetite. As BlueStone readies for its public debut, its journey will be closely watched as a bellwether for the future of omnichannel retail and the broader startup ecosystem in India.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Gujarat Penny Stock Surges 20% After ONGC Contract Win

Foreign Investors Pull Back: FPIs Exit Indian Equities for Second Straight Week

Gujarat Penny Stock Surges 20% After ONGC Contract Win

Gujarat Penny Stock Surges 20% After ONGC Contract Win

Aakash Exploration rallies after securing ₹19.36 crore order from ONGC

Gujarat-based micro-cap company *Aakash Exploration Services Ltd* saw a sharp rise in its share price, hitting the *20% upper circuit limit* after announcing a fresh order from *Oil and Natural Gas Corporation (ONGC)* worth ₹19.36 crore. This boost in stock price came as the market reacted positively to the company’s expanding portfolio of public sector projects, especially in oilfield services.

The company revealed that it had received a Letter of Intent (LOI) from ONGC to provide *mobile boiler and high-pressure steam services*. This contract adds to its growing track record of securing service-based orders from major oil and gas public sector enterprises (PSEs). Over the past few years, Aakash has built a solid presence in this niche space, successfully winning contracts exceeding ₹175 crore through competitive bidding. Its tender success rate, currently hovering around 57%, reflects its operational competence and consistent delivery.

The market responded swiftly. Following the order announcement, the stock—traditionally priced under ₹15—hit the *20% upper circuit* in intraday trading. A similar price movement was seen back in April when Aakash had secured a ₹29 crore contract from Oil India, which also triggered a strong rally. Prior to this surge, the stock was trading in the ₹7–₹9 range, and it has now approached ₹11 levels, with a 52-week low of ₹7.30 and a high of ₹17.15 recorded in July 2024.

Aakash Exploration is known for offering a range of oilfield services including *workover rigs, steam injection systems, pumping units*, and other critical equipment to India’s major oil producers like ONGC, Oil India, Indian Oil Corporation, and Vedanta. The company’s strength lies in its niche offerings, focused largely on upstream operations. Despite being a relatively small player, it has managed to consistently win sizable orders, thanks to its technical capabilities and cost-effective solutions.

Financially, Aakash remains a modest-sized firm. It has a market capitalization of around ₹80–85 crore and the promoter group holds approximately 66.6% of the company’s equity. Its recent quarterly revenue stands at ₹23–24 crore, while net profit was reported at ₹26 lakh for Q4 FY2024. While the earnings are not yet substantial, the company operates with a lean structure and continues to build a steady order book. Key financial ratios show a P/E of around 15–16 and a price-to-book value near 1.3. Its asset base is close to ₹87 crore, with net debt standing at roughly ₹25 crore.

For investors, this recent rally might present both opportunity and caution. The stock’s price action signals growing momentum among short-term traders and retail investors following news-based triggers. However, its long-term viability still depends on sustained contract wins, improved profit margins, and better scalability. Given that its revenues heavily rely on government and PSU orders, the company remains somewhat exposed to fluctuations in tendering cycles and contract renewals.

In summary, *Aakash Exploration Services Ltd* has demonstrated that even small-cap companies can generate significant market excitement when backed by meaningful contract wins. Its recent ₹19.36 crore order from ONGC not only validates its operational reliability but also boosts investor sentiment in the short term. Though the financials remain conservative, the consistent flow of PSU orders adds stability to its growth outlook.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Massive Order Lifts Solar Stock to Upper Circuit Limit

Massive Order Lifts Solar Stock to Upper Circuit Limit

Massive Order Lifts Solar Stock to Upper Circuit Limit

Massive Order Lifts Solar Stock to Upper Circuit Limit

Big Contract From Zetwerk Sends Solar Stock Higher

Ganesh Green Bharat Ltd, a rising player in India’s renewable energy space, hit the *upper circuit limit* in trading after securing a *significant ₹620.64 crore order* from Zetwerk Manufacturing Businesses Pvt Ltd. This development brought the company’s *total order book value to ₹1,173.56 crore*, reflecting substantial growth in its project backlog and future revenue potential.

The newly received contract covers the *design, supply, installation, testing, and commissioning (SITC)* of solar energy systems. It represents a landmark addition to the company’s active portfolio, which includes a wide range of infrastructure solutions such as *solar EPC services, electrical installations, and **water-related engineering works*

Prior to this deal, Ganesh Green Bharat had secured several contracts across its business segments. It held around ₹273 crore in solar project orders, approximately ₹26 crore in electrical contracts, and over ₹14 crore in water supply projects. The new order from Zetwerk not only dominates all previous individual projects by value but also *more than doubles* the company’s total work commitments, greatly enhancing its order visibility over the next several quarters.

Following the announcement, the stock was quickly locked in the *upper price band*, which restricts further upward movement for the trading session. This reaction mirrors previous surges seen when the company announced smaller contracts earlier this year, including solar pump installations and rural electrification orders, which had boosted confidence among investors.

Ganesh Green Bharat Ltd made headlines with its public debut in July 2024, when its *Initial Public Offering (IPO)* was subscribed over *12 times. Since then, the company has steadily added to its project portfolio, winning tenders under key government programs such as **Saubhagya Yojana, PM-KUSUM, and Jal Jeevan Mission. Its business model revolves around offering **EPC services for solar power systems, electrical infrastructure, and **water system projects*—sectors that are currently seeing increased public and private investment.

The company’s *market capitalization* now hovers between *₹830 and ₹1,080 crore*, depending on market conditions. This new mega order is expected to improve its earnings potential and visibility for the next few financial periods.

This Rs 620.64 crore contract could mark a turning point for the company, pushing it toward *mid-cap territory* and positioning it for larger bids in the renewable energy space. The scale of the project not only reinforces the company’s operational capabilities but also highlights the trust that large industrial players like Zetwerk place in Ganesh Green Bharat’s execution strength.

However, it’s important to note that while such big-ticket orders can fuel optimism, they also introduce new challenges. Project execution at scale, meeting deadlines, and managing supply chain risks are all factors that could affect performance. Moreover, high valuation levels post-IPO mean the company must deliver strong financials consistently to sustain investor confidence.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Fueling the Future: Investment Highlights of Sigachi’s Hyderabad Facility

Vedanta Ltd Q2 FY26: Record Revenue & EBITDA, but Exceptional Loss Weighs on Net Profit

Vedanta’s First Interim Dividend for FY26: What Investors Need to Know

Vedanta’s First Interim Dividend for FY26: What Investors Need to Know

Mining giant Vedanta announces ₹7 per share interim dividend for FY26, sets June 24 as record date, and offloads 1.6% stake in Hindustan Zinc to boost financial flexibility.

Introduction
Vedanta Limited has declared its initial interim dividend for the financial year 2025-26 at ₹7 per share with June 24, 2025, as the record date. On the same day, Vedanta sold a 1.6% stake in its subsidiary Hindustan Zinc, raising over ₹3,000 crore, a move aimed at strengthening its balance sheet and supporting its ongoing demerger plans. This article explores the implications of these developments for investors and the company’s future outlook.

Vedanta’s Dividend Announcement: Key Details
Vedanta’s Board has decided to give a first interim dividend of ₹7 per share for FY 2025-26 to investors. The total outlay for this dividend is nearly around ₹2,737 Crs. Shareholders recorded as of June 24, 2025, will be entitled to receive the dividend, which is expected to be distributed within the regulatory timeframe, generally within 30 days from the announcement.
This move continues Vedanta’s tradition of rewarding shareholders with consistent dividends. In FY25 alone, the company paid out ₹17,000 crore in dividends, translating to ₹43.5 per share. Over the past four years, Vedanta has cumulatively distributed more than ₹200 per share in dividends, underscoring its commitment to shareholder returns.

Hindustan Zinc Stake Divestment: Strengthening Balance Sheet

Vedanta Limited also offloaded a 1.6% stake in Hindustan Zinc Limited (HZL), raising approximately ₹3,028 crore from the transaction. The transaction, involving the sale of 66.7 million shares via the secondary market, was primarily directed at institutional buyers. This move aligns with Vedanta’s ongoing restructuring efforts aimed at creating independent, sector-centric businesses while boosting its overall financial agility.
The capital raised from the stake sale is intended to help de-leverage Vedanta’s balance sheet, providing the financial headroom needed for each demerged entity to pursue independent growth plans. This move also aligns with the company’s ongoing efforts to streamline operations and unlock value for shareholders.

Dividend History and Shareholder Structure
Vedanta’s dividend track record is notable for its frequency and scale. In FY24-25, the company declared four interim dividends, with payouts ranging from ₹4 to ₹20 per share. Prior to the latest declaration, Vedanta had distributed a dividend of ₹8.5 per share in December 2024, amounting to a total disbursement of ₹3,324 crore. The consistent dividend policy has made Vedanta a favorite among income-focused investors.
As of March 2025, Vedanta Resources, the parent entity, holds a 56.38% stake in Vedanta Limited, entitling it to a payout of about ₹1,543 crore from the latest dividend. Public shareholders collectively own 43.5% of the company. Significantly, Vedanta boasts a substantial retail investor presence, comprising close to 20 lakh individual shareholders who collectively hold an 11.25% ownership stake.

Financial Performance and Market Reaction
Vedanta’s recent financial results show a mixed pictureIn the fourth quarter of FY25, Vedanta posted a 1.65% sequential rise in revenue, totaling ₹40,455 crore. However, earnings before interest, tax, depreciation, and amortization (EBITDA) declined by 2.7% to ₹11,466 crore, reflecting higher operational costs. The EBITDA margin contracted to 28.34% from 29.61%, and net profit slipped by 1.8% to ₹3,483 crore.
Despite the dividend announcement and stake sale, Vedanta’s share price exhibited volatility. The stock initially rose nearly 2% but later closed 0.49% lower at ₹456 per share on June 18, 2025. This suggests that while investors welcomed the dividend, concerns about operational margins and future earnings persist.

Strategic Context: Demerger and Capital Allocation
Vedanta’s partial stake sale in Hindustan Zinc, along with its demerger initiatives, reflects a wider strategy to establish independent, sector-focused businesses. The company believes that this approach will enable each business vertical to pursue tailored growth strategies and attract focused investor interest.
The capital raised from the stake sale is expected to support these objectives, allowing Vedanta to reduce debt and invest in high-growth opportunities. For instance, Hindustan Zinc recently announced a ₹12,000 crore investment to build a new integrated zinc metal complex in Rajasthan, signaling continued expansion in core areas.

Conclusion
Vedanta’s first interim dividend for FY26 and the concurrent stake sale in Hindustan Zinc reflect a dual focus on rewarding shareholders and strengthening the company’s financial position. The dividend underscores Vedanta’s commitment to consistent payouts, while the capital raise from the stake sale provides the flexibility needed for its ambitious demerger and growth plans. Investors will be watching closely to see how these moves translate into long-term value, especially amid ongoing operational and market challenges.

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Influx Healthtech IPO: Strong Demand on Day 1!

India’s year-end IPO blitz: risks, rewards and what to watchIndia’s year-end IPO blitz: risks, rewards and what to watch

Influx Healthtech IPO: Strong Demand on Day 1!

Influx Healthtech IPO: Strong Demand on Day 1!

The ₹55.63 crore SME IPO of Influx Healthtech opens to investor interest amid solid grey market premium; analysts watch subscription numbers and market sentiment for early cues.

Summary:
Influx Healthtech launched its initial public offering (IPO) on June 18, targeting ₹55.63 crore via the SME route. The initial public offering (IPO), valued between ₹91 and ₹96 per share, is set to close on June 21, with shares expected to start trading on the NSE SME on June 25. Early interest, reflected in grey market premiums, suggests investor optimism. This article explores key IPO details, valuation, GMP trends, risk factors, and what investors should watch before applying.

IPO Overview: Influx Healthtech Hits the Market
Influx Healthtech Limited, a technology-focused company in the healthcare industry, launched its SME IPO for public subscription on June 18, 2025. The firm aims to raise ₹55.63 crore through a fresh issuance of equity shares. The price range is set between ₹91 and ₹96 per share, with investors able to bid in lots of 1,200 shares, requiring a minimum investment of ₹1,15,200 at the upper end of the price band.
The IPO will be open for subscription until June 21. Allotment details will be finalized by June 23, and shares are anticipated to be credited to demat accounts by June 24. The company’s shares are expected to start trading on the NSE SME platform on June 25.

Company Profile: A Tech-Driven Healthcare Innovator
Influx Healthtech Limited operates at the intersection of technology and healthcare, offering a suite of health-tech services ranging from AI-powered diagnostics, telemedicine platforms, to digital patient management systems. The company focuses on digitizing the healthcare value chain by working with hospitals, diagnostic labs, and individual practitioners.
Their platforms aim to solve key inefficiencies in the healthcare sector, such as patient engagement, appointment scheduling, and diagnostic result delivery. Given the rising demand for healthcare digitization in India and globally, Influx Healthtech is attempting to tap into a high-growth niche.

IPO Structure and Utilization of Proceeds
The ₹55.63 crore IPO is a 100% fresh issue, with no offer for sale (OFS) component. This means that all the proceeds will directly go to the company for its growth and expansion plans. According to the red herring prospectus:
₹20 crore will be used for technology upgradation and product development.
₹15 crore is allocated for marketing and client acquisition.
₹10 crore for infrastructure expansion, including setting up regional offices.
The remaining funds will go towards working capital and general corporate purposes.

Financials Snapshot
As per the company’s financial disclosures:
Revenue for FY24 stood at ₹35.8 crore, up from ₹24.3 crore in FY23 — a YoY growth of 47%.
Profit After Tax (PAT) rose to ₹6.9 crore in FY24 from ₹4.1 crore in FY23.
The company has achieved a robust EBITDA margin of 18.6%, highlighting its operational efficiency.
Debt levels are minimal, improving their financial risk profile ahead of listing.

Grey Market Premium (GMP) and Market Sentiment
As of Day 1, market observers report a Grey Market Premium (GMP) of ₹20–₹24 per share, indicating that the IPO is likely to list at a premium of 20–25% over the upper price band of ₹96.
The GMP trend reflects strong investor confidence and favourable sentiment towards tech-enabled SME companies. However, investors must be cautious as GMP is unofficial and speculative in nature.

Key Dates to Remember
EventDate
IPO Opening Date June 18, 2025
IPO Closing Date June 21, 2025
Basis of Allotment June 23, 2025
Credit of Shares June 24, 2025
Listing on NSE SME June 25, 2025

Valuation & Peer Comparison
At the upper price band of ₹96, Influx Healthtech is valued at a P/E ratio of around 20x based on FY24 earnings. This valuation is competitive when compared to other tech-based SMEs in the health sector, such as Docmode Health or Medtech Solutions, which are trading at P/E multiples of 25–30x.
Analysts suggest that while the valuation appears reasonable, growth sustainability and execution in the B2B health-tech domain will be critical for long-term gains.

Risk Factors to Consider
Despite the strong growth trajectory, investors should note the following risks:
Client concentration risk – a significant portion of revenue comes from a handful of hospital networks.
Tech dependency – any breach, bug, or tech downtime could significantly impact operations.
Regulatory challenges in healthcare data privacy and compliance could arise with scale.
Limited track record – while growth is visible, the company is still in the early stages of scale.

Analyst Views
Brokerage firms tracking the SME IPO space have issued a “Subscribe with Caution” recommendation. While the company’s strong growth, lean balance sheet, and sectoral tailwinds are promising, the relatively short operating history and high competitive intensity in health tech raise concerns.
Retail investors with a moderate risk appetite and long-term view may consider subscribing to the issue.

Conclusion
Influx Healthtech’s IPO comes at a time when digital transformation in the healthcare industry is accelerating. With a niche presence, healthy financials, and reasonable pricing, the IPO has generated justified market interest. However, investors must weigh the growth prospects against sector-specific risks and evolving regulatory frameworks.

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Foxconn Strengthens India Presence Amid Global Asset Shift

Foxconn Strengthens India Presence Amid Global Asset Shift

Foxconn Strengthens India Presence Amid Global Asset Shift

Foxconn Strengthens India Presence Amid Global Asset Shift

India now holds 11% of Foxconn’s global assets, reflecting a major supply chain diversification strategy by the Taiwanese electronics leader.

Foxconn, the Taiwanese electronics manufacturing giant officially known as Hon Hai Precision Industry Co., is realigning its international investment priorities. The latest company filings indicate that India now represents 11% of Foxconn’s total global assets—a clear sign that the firm is intensifying its focus on India as it seeks to lessen its dependency on Chinese operations.

This development comes at a pivotal moment, as companies around the world reassess their manufacturing and supply chain dependencies due to geopolitical uncertainties, trade barriers, and pandemic-induced disruptions.

India’s Rising Role in Foxconn’s Global Strategy

For years, Foxconn’s operations have been deeply entrenched in China, where it manufactures a majority of its electronics products, including Apple’s iPhones. However, shifts in global trade dynamics, rising production costs in China, and the ongoing U.S.-China tensions have prompted the firm to reconsider its operational blueprint.

India, with its burgeoning tech sector, skilled labor force, and proactive industrial policies, has increasingly become a prime destination for global manufacturing giants. Foxconn’s growing investment in India is not just a reflection of necessity—it’s part of a larger vision to build a more resilient, multi-country production network.

Investments Gaining Momentum Across Indian States

The company has expanded facilities in *Tamil Nadu* and *Karnataka, and initiated new projects in **Telangana*. These include large-scale electronics assembly plants, EV component manufacturing units, and even plans to enter India’s semiconductor ecosystem.

A major catalyst behind this push is India’s Production-Linked Incentive (PLI) scheme, which offers financial benefits to global manufacturers who produce high-value goods locally. With this support, Foxconn has been able to streamline its operations, boost local employment, and contribute to India’s export potential.

The company’s local arm, *Foxconn Hon Hai Technology India Mega Development*, has played a central role in overseeing this transition, acting as the operational hub for its growing Indian ventures.

Strategic Benefits of Expanding in India

Foxconn’s increased asset allocation in India brings multiple strategic advantages. Firstly, it provides the company with *geographical diversification*, reducing overexposure to any single country or political environment. Secondly, India’s growing domestic market—one of the largest for smartphones and consumer electronics—offers an additional growth frontier beyond export markets.

The nation has already seen a significant uptick in electronics exports, and major players like Foxconn are accelerating this trend by bringing advanced manufacturing technologies and processes to Indian soil.

Navigating Challenges in a New Environment

Despite its advantages, India is not without its challenges. Additionally, India is still working to match China’s scale, speed, and supply chain efficiency.

The company has demonstrated flexibility and adaptability, often adjusting project timelines or relocating facilities to more industry-friendly states.

What This Means for the Global Tech Supply Chain

It’s no longer just about cheaper labor—it’s about creating *agile, diversified, and resilient* production ecosystems.

This shift is part of a broader trend where tech giants are hedging risks and investing across multiple geographies. In this context, India stands out due to its vast market potential, improving business environment, and government-backed industrial incentives.

As Foxconn continues to build out its Indian capabilities, it’s likely that more global companies will follow suit, further cementing India’s role in the next era of high-tech manufacturing.

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Sudarshan Pharma Eyes Fundraising, Board Meet on June 19

Foxconn Strengthens India Presence Amid Global Asset Shift

Sudarshan Pharma Eyes Fundraising, Board Meet on June 19

Sudarshan Pharma Eyes Fundraising, Board Meet on June 19

The company’s board will convene to assess and approve plans for fresh capital infusion as part of its growth strategy.

Sudarshan Pharma Industries Ltd, a low-priced pharmaceutical company with a share value under ₹30, has informed the stock exchanges that its board of directors will meet on June 19, 2025. The meeting’s agenda is to review and potentially approve a plan to raise additional capital, aimed at supporting the company’s future operational and strategic objectives.

In a formal regulatory filing, the company confirmed that the board of directors will deliberate on *possible funding options, which may include issuing equity shares, convertible securities, or other instruments. These fundraising plans are aimed at **strengthening the company’s financial position* and supporting its ongoing and future expansion initiatives.

This strategic move comes as Sudarshan Pharma looks to tap into growth opportunities within the pharmaceutical and specialty chemicals sector, where it operates. The potential capital infusion is expected to help the company enhance working capital, invest in infrastructure, and pursue *new product developments*.

The company, which has a market capitalization in the *penny stock* range, has been on the radar of retail investors looking for *high-risk, high-reward opportunities* in the pharma space. Trading at less than ₹30 per share, the stock remains volatile, but any positive developments regarding funding or expansion could drive investor interest.

As of now, Sudarshan Pharma has not disclosed the exact *fundraising amount* or the instrument to be used. These specifics are likely to be decided and announced during or shortly after the June 19 board meeting. The company emphasized that the outcome of the meeting will be promptly shared in accordance with stock exchange regulations and SEBI guidelines.

It’s worth noting that many small and mid-sized pharmaceutical companies are actively exploring *external funding* to capitalize on demand for both domestic and export markets, especially in segments like *active pharmaceutical ingredients (APIs)*, intermediates, and specialty chemicals. Sudarshan Pharma’s planned fundraising initiative is likely part of a broader strategy to secure its competitive position and scale operations.

Investors and analysts will closely watch the outcome of this board meeting, as the nature and timing of the proposed capital raise could have a direct impact on the stock’s future trajectory. Any indication of institutional interest or strategic partnerships could further boost investor confidence.

At the time of the announcement, the stock continued to trade below ₹30, in line with recent trends in small-cap pharma equities. However, news of potential fundraising has already sparked curiosity in market circles.

The company has a history of engaging in contract manufacturing and product distribution for pharmaceutical companies, along with offerings in *specialty chemicals* and *nutraceuticals. Additional capital would not only provide liquidity but may also fuel its vision to **diversify and scale up operations* across different business verticals.

Summary:
Sudarshan Pharma, a budget-friendly pharma stock, has announced a board meeting set for June 19 to explore and approve new fundraising efforts. The proposed funding will be used to support the company’s financial strength and fuel its expansion plans.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

India’s Renewable IPO Wave Gains Momentum with ₹25,000 Cr Offerings